Minerva Neurosciences Revenue 2013-2019 | NERV

Minerva Neurosciences revenue from 2013 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Minerva Neurosciences Annual Revenue
(Millions of US $)
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
Minerva Neurosciences Quarterly Revenue
(Millions of US $)
Q1 2019 $0
Q4 2018 $0
Q3 2018 $0
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q2 2017 $0
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $0
Q2 2015 $0
Q1 2015 $0
Q4 2014 $0
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q4 2012 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.171B $0.000B
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company's pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD), insomnia, and Parkinson's disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.270B 34.67
Takeda Pharmaceutical (TAK) Japan $26.904B 7.90
Grifols (GRFS) Spain $13.545B 17.13
Sage Therapeutics (SAGE) United States $9.329B 0.00
Ionis Pharmaceuticals (IONS) United States $9.107B 19.91
Neurocrine Biosciences (NBIX) United States $7.829B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.485B 10.26
Catalent (CTLT) United States $7.356B 29.52
Nektar Therapeutics (NKTR) United States $6.130B 9.99
Tilray (TLRY) Canada $3.991B 0.00
FibroGen (FGEN) United States $3.795B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.537B 12.41
United Therapeutics (UTHR) United States $3.444B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.644B 398.43
PTC Therapeutics (PTCT) United States $2.497B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.091B 7.53
Xencor (XNCR) United States $1.946B 53.14
Portola Pharmaceuticals (PTLA) United States $1.915B 0.00
Tricida (TCDA) United States $1.836B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.808B 87.54
Enanta Pharmaceuticals (ENTA) United States $1.789B 24.45
Ironwood Pharmaceuticals (IRWD) United States $1.778B 0.00
USANA Health Sciences (USNA) United States $1.738B 15.10
Zogenix (ZGNX) United States $1.689B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.589B 0.00
Aerie Pharmaceuticals (AERI) United States $1.554B 0.00
Heron Therapeutics (HRTX) United States $1.444B 0.00
Esperion Therapeutics (ESPR) United States $1.373B 0.00
Turning Point Therapeutics (TPTX) United States $1.361B 0.00
Corcept Therapeutics (CORT) United States $1.206B 17.21
Radius Health (RDUS) United States $1.096B 0.00
ArQule (ARQL) United States $1.023B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.949B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.932B 0.00
Endo (ENDP) Ireland $0.896B 1.44
Odonate Therapeutics (ODT) United States $0.719B 0.00
Aptorum Group (APM) China $0.694B 0.00
CannTrust Holdings (CTST) Canada $0.673B 0.00
Organogenesis Holdings (ORGO) United States $0.671B 0.00
TherapeuticsMD (TXMD) United States $0.625B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.584B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.561B 0.00
Akebia Therapeutics (AKBA) United States $0.539B 0.00
Dermira (DERM) United States $0.537B 0.00
Translate Bio (TBIO) United States $0.519B 0.00
ChemoCentryx (CCXI) United States $0.506B 0.00
GlycoMimetics (GLYC) United States $0.503B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.452B 0.00
Flexion Therapeutics (FLXN) United States $0.448B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.433B 21.85
Siga Technologies (SIGA) United States $0.432B 1.02
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.391B 0.00
TCR2 Therapeutics (TCRR) United States $0.389B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.386B 0.00
Collegium Pharmaceutical (COLL) United States $0.379B 0.00
Karyopharm Therapeutics (KPTI) United States $0.360B 0.00
KalVista Pharmaceuticals (KALV) United States $0.352B 0.00
Rafael Holdings (RFL) United States $0.345B 0.00
Forty Seven (FTSV) United States $0.329B 0.00
ImmunoGen (IMGN) United States $0.321B 0.00
CASI Pharmaceuticals (CASI) United States $0.306B 0.00
Harpoon Therapeutics (HARP) United States $0.295B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.286B 0.00
OptiNose (OPTN) United States $0.285B 0.00
Xeris Pharmaceuticals (XERS) United States $0.284B 0.00
Molecular Templates (MTEM) United States $0.282B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.264B 0.00
Concert Pharmaceuticals (CNCE) United States $0.261B 0.00
Dova Pharmaceuticals (DOVA) United States $0.252B 0.00
Aratana Therapeutics (PETX) United States $0.239B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.233B 0.00
Recro Pharma (REPH) United States $0.214B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.214B 0.00
Lannett Co Inc (LCI) United States $0.214B 2.08
Aclaris Therapeutics (ACRS) United States $0.202B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.198B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.191B 0.00
Aldeyra Therapeutics (ALDX) United States $0.188B 0.00
Calithera Biosciences (CALA) United States $0.186B 0.00
MEI Pharma (MEIP) United States $0.185B 0.00
Bio Blast Pharma (ENLV) Israel $0.177B 0.00
Galectin Therapeutics (GALT) United States $0.176B 0.00
Opexa Therapeutics (ACER) United States $0.176B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.175B 0.00
IMV INC (IMV) Canada $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 55.44
Jounce Therapeutics (JNCE) United States $0.159B 0.00
Ardelyx (ARDX) United States $0.157B 0.00
Redhill Biopharma (RDHL) Israel $0.154B 0.00
Majesco Entertainment (PTE) United States $0.147B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.145B 0.00
Neon Therapeutics (NTGN) United States $0.141B 0.00
AgeX Therapeutics (AGE) United States $0.135B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Tyme Technologies (TYME) United States $0.122B 0.00
Aquestive Therapeutics (AQST) United States $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.116B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.108B 0.00
MediWound (MDWD) Israel $0.097B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 68.89
Iterum Therapeutics (ITRM) Ireland $0.095B 0.00
Avenue Therapeutics (ATXI) United States $0.094B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.093B 0.00
Natural Alternatives (NAII) United States $0.092B 9.17
DURECT (DRRX) United States $0.092B 0.00
Cardiome Pharma (CORV) Canada $0.092B 0.00
Infinity Pharmaceuticals (INFI) United States $0.091B 0.00
Capnia (SLNO) United States $0.090B 0.00
Mast Therapeutics (SVRA) United States $0.085B 0.00
Adherex Technologies (FENC) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Nivalis Therapeutics (ALPN) United States $0.081B 0.00
Otonomy (OTIC) United States $0.078B 0.00
China SXT Pharmaceuticals (SXTC) China $0.077B 0.00
Genocea Biosciences (GNCA) United States $0.072B 0.00
Novan (NOVN) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
Neos Therapeutics (NEOS) United States $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Zafgen (ZFGN) United States $0.052B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.051B 0.00
KemPharm (KMPH) United States $0.051B 0.00
AIT Therapeutics (AITB) Israel $0.050B 0.00
India Globalization Capital (IGC) United States $0.049B 0.00
ProNAi Therapeutics (SRRA) Canada $0.048B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.044B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
Bio-Path Holdings (BPTH) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
ContraFect (CFRX) United States $0.039B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.038B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.032B 0.00
IsoRay (ISR) United States $0.029B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.028B 0.00
Heat Biologics (HTBX) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
Biomerica (BMRA) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.021B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.59
Pain Therapeutics (SAVA) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
PRECISION THERAPEUTICS INC (POAI) United States $0.018B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.78
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00